 |
|
|
|
August 2007 Cover
|
|
A peptide found in human blood appears, in lab tests, to prevent 60 different strains of HIV from infecting cells, German researchers report. The peptide, called VIRIP, targets the gp41 protein on the surface of HIV, which the virus uses to penetrate the surface of CD4 cells.
The discovery could pave the way for a new class of antiretrovirals, and may also have applications as a microbicide.
Unfortunately, like enfuvirtide (T-20, Fuzeon), a VIRIP-based drug would be expensive to produce and would require administration via injection.
from TheBodyPro.com
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
